Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
36.10B | 34.54B | 31.40B | 31.67B | 33.33B | Gross Profit |
7.72B | 7.06B | 6.77B | 6.60B | 6.52B | EBIT |
882.77M | 548.46M | 559.51M | 778.10M | 399.63M | EBITDA |
1.99B | 1.58B | 1.83B | 242.25M | 1.34B | Net Income Common Stockholders |
779.85M | 331.34M | 750.84M | -847.08M | 268.36M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.48B | 8.26B | 7.56B | 6.49B | 4.66B | Total Assets |
28.36B | 27.20B | 27.05B | 24.89B | 23.84B | Total Debt |
4.98B | 5.13B | 3.82B | 3.33B | 2.47B | Net Debt |
-3.50B | -3.12B | -3.74B | -3.16B | -2.07B | Total Liabilities |
13.14B | 13.00B | 13.22B | 11.36B | 9.84B | Stockholders Equity |
15.22B | 14.20B | 13.82B | 13.53B | 14.00B |
Cash Flow | Free Cash Flow | |||
924.34M | -502.24M | 345.68M | 1.30B | -706.18M | Operating Cash Flow |
1.68B | 790.45M | 1.75B | 2.51B | 1.11B | Investing Cash Flow |
-1.20B | -1.21B | -889.09M | -1.31B | -1.76B | Financing Cash Flow |
-253.79M | 1.16B | 310.62M | 607.72M | 399.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $6.23T | 31.05 | 20.56% | 0.88% | 13.56% | 12.76% | |
77 Outperform | ¥5.40B | 5.12 | 2.38% | 10.40% | 60.55% | ||
77 Outperform | ¥16.77T | 27.44 | 10.50% | 1.06% | 0.56% | 5.32% | |
72 Outperform | ¥4.38T | 25.34 | 3.42% | 9.08% | -33.61% | ||
70 Outperform | ¥3.94T | 11.82 | 7.23% | 2.19% | 1.72% | -33.60% | |
66 Neutral | $853.65B | 114.83 | 0.98% | 2.29% | -6.57% | -76.15% | |
64 Neutral | $4.27B | 11.80 | 5.31% | 249.79% | 4.07% | -9.02% |